
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine Society’s […]